In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis.
The diuretic amiloride has been under recent investigation as adjunctive therapy for pulmonary disease in children with cystic fibrosis (CF). In preliminary studies, the antimicrobial activity of this agent alone or combined with beta-lactam agents against reference strains of Pseudomonas aeruginosa...
I tiakina i:
| I whakaputaina i: | Antimicrob Agents Chemother |
|---|---|
| Ngā kaituhi matua: | , , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
American Society for Microbiology (ASM)
1988
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172183/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3364958/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.3.395 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|